HAE vs NHC

HAE exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating a robust financial trajectory. While the stock is currently trading above its Graham Number ($39.87), it remains significantly undervalued relative to its growth-based intrinsic value ($107.08) and a PEG ratio of 0.92. Despite a bearish technical trend and slight revenue contraction (-2.70%), the company demonstrates exceptional operational efficiency with 28.4% earnings growth and a consistent track record of beating EPS estimates. The divergence between strong internal fundamentals and poor price performance suggests a value opportunity.

NHC exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a nearly debt-free balance sheet (Debt/Equity 0.08). While the stock trades below its growth-based intrinsic value of $226.26, it is currently priced above its defensive Graham Number of $108.96. The outlook is tempered by a concerning Forward P/E of 403.00 and a streak of four consecutive earnings misses, suggesting a significant projected decline in profitability. Despite strong long-term price appreciation, the current technical trend is heavily bearish (10/100), indicating a potential short-term reversal or consolidation phase.